Director's Dealing • Oct 16, 2018
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 1971E
Surgical Innovations Group PLC
16 October 2018
(the "Company")
The Company has been notified that Nigel Rogers, Executive Chairman, today:
(i) acquired 750,000 ordinary shares of 1 penny each in the Company ("Shares") within his ISA, at a price of 2.95p per share; and
(ii) sold 416,830 Shares at a price of 2.95p per share.
Following these transactions, the beneficial holding of Nigel Rogers in the Company is 6,610,000
Shares, representing approximately 0.84% of the issued share capital of the Company.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
| Surgical Innovations Group plc Nigel Rogers, Executive Chairman Melanie Ross, COO & CFO WH Ireland Limited (NOMAD & Broker) Tim Feather Walbrook PR (Financial PR & Investor Relations) Paul McManus Lianne Cawthorne |
www.sigroupplc.com |
| Tel: 0113 230 7597 | |
| Tel: 0113 394 6600 | |
| Tel: 020 7933 8780 or [email protected] | |
| Mob: 07980 541893 | |
| Mob: 07584 391303 |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Nigel Rogers | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Executive Chairman, Surgical Innovations Group plc | ||||
| b) | Initial notification/ Amendment | Initial Notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Surgical Innovations Group plc | ||||
| b) | LEI | 2138004GHGUH3HUZE156 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1p GB0004016704 |
||||
| b) | Nature of the transactions | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |||
| 2.95p | 750,000 | |||||
| d) | Aggregated information - Aggregated volume - Price |
750,000 £22,125 |
||||
| e) | Date of the transaction | 16 October 2018 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name | Nigel Rogers | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Executive Chairman, Surgical Innovations Group plc | |||
| b) | Initial notification/ Amendment | Initial Notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Surgical Innovations Group plc | |||
| b) | LEI | 2138004GHGUH3HUZE156 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1p GB0004016704 |
|||
| b) | Nature of the transactions | Sale of Ordinary Shares | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| 2.95p | 416,830 | ||||
| d) | Aggregated information - Aggregated volume - Price |
416,830 £12,296 |
|||
| e) | Date of the transaction | 16 October 2018 | |||
| f) | Place of the transaction | London Stock Exchange, AIM |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHGCBDGCSBBGIL
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.